Study to Evaluate the Safety, Pharmacokinetics and Efficacy of Recombinant Factor VIII Fc Fusion Protein (rFVIIIFc) in Previously Treated Subjects With Severe Hemophilia A
Clinical trial NCT01181128 · COMPLETED
Trial details
- NCT number
- NCT01181128
- Sponsor
- Bioverativ Therapeutics Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-11-01
- Primary completion
- 2012-08-01
- Enrollment
- 165
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.